IDeA Entrepreneurship Training and Community Development

IDeA创业培训和社区发展

基本信息

项目摘要

Summary Scientists are motivated by the notion that their work could improve or save lives; however, moving medical innovations from bench to bedside is challenging. Biomedical entrepreneurship can be a career choice but is also key to translating these investments in medical research by the commercialization of innovative ideas. To succeed at this translation, a whole new set of skills are required, such as; understanding the barriers to adoption in the complex healthcare market, business plan development, regulatory requirements, securing the financial resources, and protection of intellectual property. Training in biomedical entrepreneurship is limited in the Institutional Development Award program (IDeA)-eligible states. We posit that innovative training opportunities that close this foundational knowledge and skills gap will speed the commercialization of biomedical inventions and career progression. To address this need and education gap we established the IDeA-Entrepreneurship (I-Trep) training program. The overall goal of I-Trep is to promote entrepreneurship in biomedical research and to jump start and facilitate the transition of innovative ideas and discoveries from the laboratory or bedside into the marketplace. To date, we have engaged seven target states (VT, NH, ME, RI, DE, AK and Puerto Rico) and moved careers forward. We have trained or assisted a highly diverse group of scientists, who have raised to date $8 million in SBIR/STTR grant dollars and two I-Trep -assisted companies have now raised $20 million from private investors. I-Trep is being revamped with a next phase of development, innovation, and expansion to create an IDeA entrepreneurial ecosystem. We will now move forward to engage the entire IDeA program of 23 states plus Puerto Rico with the aims and goals for the next phase that are: 1) Promote early career training in biomedical entrepreneurship through innovative training opportunities. This will be achieved using innovative principles of active learning, we will deploy virtual and asynchronous learning opportunities, an I-Trep Studio program, and an I-Trep Fellows program. 2) Build a virtual community of practice. Mentoring of early- stage entrepreneurs will be achieved through the establishment of an online community of practice (ecosystem)- allowing members to a) connect with peer mentors, b) received one-on-one mentoring from vetted consultants, c) find internship opportunities to gain practical experience. and 3) Marketing. We will disseminate our training program by using a multifaceted approach that is grounded in best practices and innovations in communications and build the community of practice in collaboration with several NIGMS Regional Technology Transfer Hubs. I-Trep fills a unique niche through the education and training of academic scientists so that they can interact more effectively with business professionals and thus realize the successful translation of scientific discoveries to market.
概括 科学家们的动力来自于他们的工作可以改善或拯救生命。然而,移动医疗 从实验室到临床的创新具有挑战性。生物医学创业可以是一种职业选择,但 通过将创新理念商业化,将这些投资转化为医学研究也是关键。 为了成功完成这种翻译,需要一套全新的技能,例如:了解障碍 复杂的医疗保健市场的采用、业务计划制定、监管要求、安全 财政资源和知识产权保护。生物医药创业培训是 仅限于符合机构发展奖计划 (IDeA) 资格的州。我们认为创新 缩小这一基础知识和技能差距的培训机会将加速商业化 生物医学发明和职业发展。为了解决这一需求和教育差距,我们建立了 IDeA-创业精神(I-Trep)培训计划。 I-Trep 的总体目标是促进 生物医学研究领域的创业精神,以及快速启动和促进创新转型 将实验室或床边的想法和发现推向市场。迄今为止,我们已参与 七个目标州(VT、NH、ME、RI、DE、AK 和波多黎各)并推动职业发展。我们训练过 或协助高度多元化的科学家群体,他们迄今已筹集 800 万美元的 SBIR/STTR 拨款 两家 I-Trep 协助的公司现已从私人投资者那里筹集了 2000 万美元。 I-Trep 正在 进行下一阶段的开发、创新和扩张,打造 IDeA 创业企业 生态系统。我们现在将继续让 23 个州以及波多黎各的整个 IDeA 计划与 下一阶段的目的和目标是: 1) 促进生物医学领域的早期职业培训 通过创新培训机会创业。这将通过创新来实现 主动学习的原则,我们将部署虚拟和异步学习机会,I-Trep Studio 计划和 I-Trep 研究员计划。 2)建立虚拟实践社区。早期辅导—— 通过建立在线实践社区来实现阶段企业家 (生态系统)- 允许成员 a) 与同行导师联系,b) 接受来自同行的一对一指导 经过审查的顾问,c) 寻找实习机会以获得实践经验。 3) 营销。我们将 通过使用基于最佳实践的多方面方法来传播我们的培训计划 通信创新并与多个 NIGMS 合作建立实践社区 区域技术转移中心。 I-Trep 通过教育和培训填补了独特的空白 学术科学家,以便他们能够与商业专业人士更有效地互动,从而实现 将科学发现成功转化为市场。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles G Irvin其他文献

C5A DES ARG-INDUCED SINUSITIS IN RABBITS: EFFECT ON BRONCHIAL REACTIVITY TO HISTAMINE
  • DOI:
    10.1203/00006450-198404001-01774
  • 发表时间:
    1984-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Nancy P Cummings;Charles G Irvin;Christopher Haslett;Peter M Henson
  • 通讯作者:
    Peter M Henson

Charles G Irvin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles G Irvin', 18)}}的其他基金

IDeA Entrepreneurship Training and Community Development
IDeA创业培训和社区发展
  • 批准号:
    10703427
  • 财政年份:
    2022
  • 资助金额:
    $ 48.6万
  • 项目类别:
Deep Functional Phenotyping of the ALA Lung Health Cohort
ALA 肺部健康队列的深层功能表型分析
  • 批准号:
    10685503
  • 财政年份:
    2022
  • 资助金额:
    $ 48.6万
  • 项目类别:
TRANSLATIONAL RESEARCH IN LUNG BIOLOGY AND DISEASE
肺生物学和疾病的转化研究
  • 批准号:
    8364916
  • 财政年份:
    2011
  • 资助金额:
    $ 48.6万
  • 项目类别:
Translational Research in Lung Biology and Disease
肺生物学和疾病的转化研究
  • 批准号:
    8126199
  • 财政年份:
    2010
  • 资助金额:
    $ 48.6万
  • 项目类别:
Translational Research in Lung Biology and Disease
肺生物学和疾病的转化研究
  • 批准号:
    8137515
  • 财政年份:
    2010
  • 资助金额:
    $ 48.6万
  • 项目类别:
Translational Research in Lung Biology and Disease
肺生物学和疾病的转化研究
  • 批准号:
    7939084
  • 财政年份:
    2010
  • 资助金额:
    $ 48.6万
  • 项目类别:
Translational Research in Lung Biology and Disease
肺生物学和疾病的转化研究
  • 批准号:
    8542877
  • 财政年份:
    2010
  • 资助金额:
    $ 48.6万
  • 项目类别:
Translational Research in Lung Biology and Disease
肺生物学和疾病的转化研究
  • 批准号:
    8723247
  • 财政年份:
    2010
  • 资助金额:
    $ 48.6万
  • 项目类别:
Translational Research in Lung Biology and Disease
肺生物学和疾病的转化研究
  • 批准号:
    8138205
  • 财政年份:
    2010
  • 资助金额:
    $ 48.6万
  • 项目类别:
Translational Research in Lung Biology and Disease
肺生物学和疾病的转化研究
  • 批准号:
    8319673
  • 财政年份:
    2010
  • 资助金额:
    $ 48.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了